Top Growth Stocks With Insider Backing In December 2024

In This Article:

As global markets navigate a period of mixed performances, with the Nasdaq Composite reaching new heights while other indices face declines, investors are keenly observing the Federal Reserve's anticipated rate cut. In this environment, growth stocks with substantial insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and potential.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Seojin SystemLtd (KOSDAQ:A178320)

30.9%

39.9%

SKS Technologies Group (ASX:SKS)

27%

24.8%

Laopu Gold (SEHK:6181)

36.4%

34.2%

Medley (TSE:4480)

34%

31.7%

Plenti Group (ASX:PLT)

12.8%

120.1%

Brightstar Resources (ASX:BTR)

16.2%

84.5%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

131.1%

Fulin Precision (SZSE:300432)

13.6%

66.7%

HANA Micron (KOSDAQ:A067310)

18.5%

110.9%

Findi (ASX:FND)

34.8%

112.9%

Click here to see the full list of 1567 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) is a Swedish company focused on developing biological drugs for central nervous system disorders, with a market cap of SEK19.46 billion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to SEK167.14 million.

Insider Ownership: 34%

Earnings Growth Forecast: 62.5% p.a.

BioArctic's insider ownership reflects strong internal confidence, with recent developments highlighting its growth potential. The company entered a lucrative agreement with Bristol Myers Squibb for its PyroGlu-Ab antibody program, securing a US$100 million upfront and up to US$1.25 billion in milestone payments, plus royalties. Despite recent financial losses, BioArctic's revenue is forecasted to grow significantly faster than the Swedish market at 49.2% annually, supported by promising advancements in Alzheimer's and Parkinson's treatments.

OM:BIOA B Earnings and Revenue Growth as at Dec 2024
OM:BIOA B Earnings and Revenue Growth as at Dec 2024

Lucky Harvest

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lucky Harvest Co., Ltd. operates in China, focusing on the research, development, production, and sale of precision stamping dies and structural metal parts, with a market cap of CN¥6.73 billion.

Operations: The company's revenue segments include precision stamping dies and structural metal parts.

Insider Ownership: 33.1%